OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
JAK/STAT signaling in hepatocellular carcinoma
Justin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
Hepatic Oncology (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 125
Justin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
Hepatic Oncology (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 125
Showing 1-25 of 125 citing articles:
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review
Teklie Mengie Ayele, Zelalem Tilahun Muche, Awgichew Behaile Teklemariam, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 1349-1364
Open Access | Times Cited: 129
Teklie Mengie Ayele, Zelalem Tilahun Muche, Awgichew Behaile Teklemariam, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 1349-1364
Open Access | Times Cited: 129
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
Deniz Tümen, Philipp Heumann, Karsten Gülow, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3202-3202
Open Access | Times Cited: 81
Deniz Tümen, Philipp Heumann, Karsten Gülow, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3202-3202
Open Access | Times Cited: 81
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 32
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 32
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 27
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 27
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 18
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 18
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Targeting the JAK/STAT pathway in solid tumors
Zoya Qureshy, Daniel E. Johnson, Jennifer R. Grandis
Journal of Cancer Metastasis and Treatment (2020) Vol. 2020
Open Access | Times Cited: 114
Zoya Qureshy, Daniel E. Johnson, Jennifer R. Grandis
Journal of Cancer Metastasis and Treatment (2020) Vol. 2020
Open Access | Times Cited: 114
Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights
Nouf Juaid, Amr Amin, Ali Abdalla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10774-10774
Open Access | Times Cited: 83
Nouf Juaid, Amr Amin, Ali Abdalla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10774-10774
Open Access | Times Cited: 83
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3057-3057
Open Access | Times Cited: 78
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3057-3057
Open Access | Times Cited: 78
Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review
Ahmed Ismail, Hesham A. El-Mahdy, Ahmed I. Abulsoud, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 1541-1565
Closed Access | Times Cited: 66
Ahmed Ismail, Hesham A. El-Mahdy, Ahmed I. Abulsoud, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 1541-1565
Closed Access | Times Cited: 66
Immunotherapies for hepatocellular carcinoma
Justin K. H. Liu, Andrew F. Irvine, Rebecca Jones, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 571-591
Open Access | Times Cited: 63
Justin K. H. Liu, Andrew F. Irvine, Rebecca Jones, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 571-591
Open Access | Times Cited: 63
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153886-153886
Closed Access | Times Cited: 60
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153886-153886
Closed Access | Times Cited: 60
The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1931-1931
Open Access | Times Cited: 57
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1931-1931
Open Access | Times Cited: 57
Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases
Hamidreza Zalpoor, Mohsen Nabi‐Afjadi, Razieh Forghaniesfidvajani, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Hamidreza Zalpoor, Mohsen Nabi‐Afjadi, Razieh Forghaniesfidvajani, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
Hyun-Jung Park, S.-H. Lee, Jaehun Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13764-13764
Open Access | Times Cited: 25
Hyun-Jung Park, S.-H. Lee, Jaehun Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13764-13764
Open Access | Times Cited: 25
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 15
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Yangtao Xue, Yeling Ruan, Yali Wang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Yangtao Xue, Yeling Ruan, Yali Wang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107696-107696
Closed Access | Times Cited: 9
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107696-107696
Closed Access | Times Cited: 9
Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma
Jiazhou Ye, Xing Gao, Xi huang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 8
Jiazhou Ye, Xing Gao, Xi huang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 8
PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Life Sciences (2020) Vol. 256, pp. 117899-117899
Closed Access | Times Cited: 65
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Life Sciences (2020) Vol. 256, pp. 117899-117899
Closed Access | Times Cited: 65
Hepcidin in hepatocellular carcinoma
Jonathan H. Joachim, Kosha J. Mehta
British Journal of Cancer (2022) Vol. 127, Iss. 2, pp. 185-192
Open Access | Times Cited: 33
Jonathan H. Joachim, Kosha J. Mehta
British Journal of Cancer (2022) Vol. 127, Iss. 2, pp. 185-192
Open Access | Times Cited: 33
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 29
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 29
